DXCM 241129 76.00C (DXCM241129C76000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

DXCM241129C76000

Watchlist

2.28
+0.08+3.64%

15min DelayClose Nov 27 16:00 ET

2.29High1.79Low

Intraday

5D
Daily

News

Wednesday Ends With Index Decline | Wall Street Today
Kevin Travers16:08 ET
Dow Hits Another Record, Core PCE 2.8% as Expected | Live Stock
Kevin TraversNov 27 09:57 ET
Why Is DexCom, Inc. (DXCM) Among the Worst Performing Healthcare Stocks in 2024?
Yahoo FinanceNov 27 09:28 ET
S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today
Kevin TraversNov 26 16:12 ET
Dow Falls After Record, Trump Talks Tariffs on Day One | Live Stock
Kevin TraversNov 26 10:02 ET
DexCom, Inc. (DXCM): Innovation and Growth Catalysts Amid Strong Long-Term Outlook for Diabetes Care
Yahoo FinanceNov 25 17:21 ET

Comments

Diablo111

Yesterday 09:22

$DexCom (DXCM.US)$

Share Your Profit/Loss

Autistic Gains

Oct 25 16:10

$DexCom (DXCM.US)$ 5k gone lol was worth the chance maybe next week

Autistic Gains

Oct 25 08:35

$DexCom (DXCM.US)$ 420 contracts for $83 calls at .05 lotto

Autistic Gains

Oct 25 08:21

🤪

$DexCom (DXCM.US)$ now buy crazy calls muhahahaha

BullnBearTrading

Oct 25 02:31

DexCom Stock Dips After Q3 Results and Leadership Announcement

$DexCom (DXCM.US)$ reported Q3 earnings of 45 cents per share, slightly beating the 43-cent analyst estimate.
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...